EVALUATION OF EARLY VIROLOGIC RESPONSE RATE TO PEGINTERFERON PLUS RIBAVIRIN COMBINATION THERAPY IN HEREDITARY COAGULATION DISORDER PATIENTS WITH CHRONIC HEPATITIS

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

SOMI MOHAMMAD HUSSEIN; SEPEHRI BITA; GHAFFARI REZA; DOLATKHAH ROYA; MAJIDI NEGAR; SALEKRANJBAR FARIBA

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: MEDICAL JOURNAL OF TABRIZ UNIVERSITY OF MEDICAL SCIENCES Year:2011 | Volume:33 | Issue:1 Page(s): 47-52

Download Full-Text

Persian Verion

View:

1,690

Download:

Cites:

Information Journal Paper

Title

EVALUATION OF EARLY VIROLOGIC RESPONSE RATE TO PEGINTERFERON PLUS RIBAVIRIN COMBINATION THERAPY IN HEREDITARY COAGULATION DISORDER PATIENTS WITH CHRONIC HEPATITIS

Author(s)

Keywords

HEREDITARY COAGULATIVE DISORDER PATIENTSQ2

CHRONIC HEPATITIS CQ2

RESPONSE TO TREATMENTQ2

PEGINTERFERONQ3

RIBAVIRINQ2

Abstract

Background and Objectives: The hereditary coagulation disorder patients are excessively at risk for hepatitis C virus (HCV) due to multiple blood and coagulation factors transfusions. Hepatitis C treatment was first based on the use of interferon alpha but later combination therapy with PEGINTERFERON plus RIBAVIRIN increased the sustained virologic response to 50%. The present study aimed to evaluate the response rate to treatment with PEGINTERFERON plus RIBAVIRIN in HEREDITARY COAGULATIVE DISORDER PATIENTS with CHRONIC HEPATITIS C.Materials and Methods: This study is a descriptive analytical and applied study without control group. Forty HCV positive HEREDITARY COAGULATIVE DISORDER PATIENTS referred to our clinic during 2007-2008 were enrolled. Liver biopsy was not performed in any of the studied patients due to its potential risks. Treatment included PEGINTERFERON alpha-2a (180 mg/week) plus RIBAVIRIN (800-1200 mg/day) for 24-48 weeks. Early virologic response (EVR) was defined as a negative HCV-RNA level at the end of 12 weeks of treatment.Results: In 12.9% of the patients, a positive history of previous treatment for hepatitis C with interferon and RIBAVIRIN was found. Virus genotype was 1b in 21.9% of patients, 1a in 37.5% and 3a in 34.4% and a combination of 3a and 1a in 6.3%. The mean pretreatment viral load was 1220183.7 copies/mL and viral load after 3-month treatment was zero (P<0.001).Conclusion: Among EVR enhancing factors (low virus level and young age of the patients), the young age was an important factor leading to full EVR achievement. Lack of severe complications and appropriate drug response excluding the viral genotype is indicative of the advantages of combination therapy of PEGINTERFERON plus RIBAVIRIN in HEREDITARY COAGULATIVE DISORDER PATIENTS with CHRONIC HEPATITIS C.

Cites

No record.

References

No record.

Cite

APA: Copy

SOMI, MOHAMMAD HUSSEIN, SEPEHRI, BITA, GHAFFARI, REZA, DOLATKHAH, ROYA, MAJIDI, NEGAR, & SALEKRANJBAR, FARIBA. (2011). EVALUATION OF EARLY VIROLOGIC RESPONSE RATE TO PEGINTERFERON PLUS RIBAVIRIN COMBINATION THERAPY IN HEREDITARY COAGULATION DISORDER PATIENTS WITH CHRONIC HEPATITIS. MEDICAL JOURNAL OF TABRIZ UNIVERSITY OF MEDICAL SCIENCES, 33(1), 47-52. SID. https://sid.ir/paper/47234/en

Vancouver: Copy

SOMI MOHAMMAD HUSSEIN, SEPEHRI BITA, GHAFFARI REZA, DOLATKHAH ROYA, MAJIDI NEGAR, SALEKRANJBAR FARIBA. EVALUATION OF EARLY VIROLOGIC RESPONSE RATE TO PEGINTERFERON PLUS RIBAVIRIN COMBINATION THERAPY IN HEREDITARY COAGULATION DISORDER PATIENTS WITH CHRONIC HEPATITIS. MEDICAL JOURNAL OF TABRIZ UNIVERSITY OF MEDICAL SCIENCES[Internet]. 2011;33(1):47-52. Available from: https://sid.ir/paper/47234/en

IEEE: Copy

MOHAMMAD HUSSEIN SOMI, BITA SEPEHRI, REZA GHAFFARI, ROYA DOLATKHAH, NEGAR MAJIDI, and FARIBA SALEKRANJBAR, “EVALUATION OF EARLY VIROLOGIC RESPONSE RATE TO PEGINTERFERON PLUS RIBAVIRIN COMBINATION THERAPY IN HEREDITARY COAGULATION DISORDER PATIENTS WITH CHRONIC HEPATITIS,” MEDICAL JOURNAL OF TABRIZ UNIVERSITY OF MEDICAL SCIENCES, vol. 33, no. 1, pp. 47–52, 2011, [Online]. Available: https://sid.ir/paper/47234/en

Related Journal Papers